Holmes supports SB2762 mandate for insurance to cover seizure detection devices

Sen. Linda Holmes (D-42nd) supported SB2762 with a Yes vote on May 31, 2026, during the 104th General Assembly; as reported by the Illinois Senate, the bill was approved 53-5.

The bill's official description reads: "INS-SEIZURE DETECTION DEVICE."

The summary presented below distills and, where necessary, interprets the actual language of the bill to clarify its intent and scope.

This measure mandates that most individual and group health insurance plans—including those from state, local government, school, HMO, limited health service, voluntary health service and Medicaid plans—must cover FDA-cleared seizure detection devices when prescribed by a physician, beginning Jan. 1, 2027. Qualifying devices comprise technology that monitors, predicts, alerts or collects seizure data. Prior authorization and most patient out-of-pocket costs are prohibited, except in cases preserving eligibility for high-deductible plans with health savings accounts. The law becomes effective upon enactment.

For SB2762, the action recorded was 'House Floor Amendment No. 3 Senate Concurs'.

Holmes earned a Bachelor of Arts from National College of Education in 1984.

A Democrat, Holmes has represented the 42nd Senate District in the Illinois State Senate since her election in 2007, succeeding former state senator Phyllis Petka.

Illinois bills are considered through a multi-step legislative process, involving introduction in one chamber, review by committee, floor debate, and approval from both House and Senate before final consideration by the governor. The General Assembly operates on a two-year cycle, and although many bills are filed, only some advance through all stages to become law.